Schunkert H; Koenig IR; Kathiresan S; Reilly MP; Assimes TL; Holm H; Preuss M; Stewart AFR; Barbalic M; Gieger C; Absher D; Aherrahrou Z; Allayee H; Altshuler D; Anand SS; Andersen K; Anderson JL; Ardissino D; Ball SG; Balmforth AJ; Barnes TA; Becker DM; Becker LC; Berger K; Bis JC; Boekholdt SM; Boerwinkle E; Braund PS; Brown MJ; Burnett MS; Buysschaert I; Carlquist JF; Chen L; Cichon S; Codd V; Davies RW; Dedoussis G; Dehghan A; Demissie S; Devaney JM; Diemert P; Do R; Doering A; Eifert S; El Mokhtari NE; Ellis SG; Elosua R; Engert JC; Epstein SE; de Faire U; Fischer M; Folsom AR; Freyer J; Gigante B; Girelli D; Gretarsdottir S; Gudnason V; Gulcher JR; Halperin E; Hammond N; Hazen SL; Hofman A; Horne BD; Illig T; Iribarren C; Jones GT; Jukema JW; Kaiser MA; Kaplan LM; Kastelein JJP; Khaw K; Knowles JW; Kolovou G; Kong A; Laaksonen R; Lambrechts D; Leander K; Lettre G; Li M; Lieb W; Loley C; Lotery AJ; Mannucci PM; Maouche S; Martinelli N; McKeown PP; Meisinger C; Meitinger T; Melander O; Merlini PA; Mooser V; Morgan T; Muehleisen TW; Muhlestein JB; Muenzel T; Musunuru K; nahrstaedt J; Nelson CP; Noethen MM; Olivieri O; Patel RS; Patterson CC; Peters A; Peyvandi F; Qu L; Quyyumi AA; Rader DJ; Rallidis LS; Rice C; Rosendaal FR; Rubin D; Salomaa V; Sampietro ML; Sandhu MS; Schadt E; Schaefer A; Schillert A; Schreiber S; Schrezenmeir J; Schwartz SM; Siscovick DS; Sivananthan M; Sivapalaratnam S; Smith A; Smith TB; Snoep JD; Soranzo N; Spertus JA; Stark K; Stirrups K; Stoll M; Tang WHW; Tennstedt S; Thorgeirsson G; Thorleifsson G; Tomaszewski M; Uitterlinden AG; van Rij AM; Voight BF; Wareham NJ; Wells GA; Wichmann H; Wild PS; Willenborg C; Witteman JCM; Wright BJ; Ye S; Zeller T; Ziegler A; Cambien F; Goodall AH; Cupples LA; Quertermous T; Maerz W; Hengstenberg C; Blankenberg S; Ouwehand WH; Hall AS; Deloukas P; Thompson JR; Stefansson K; Roberts R; Thorsteinsdottir U; O'Donnell CJ; McPherson R; Erdmann J; Samani NJ; Consortium C (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. NATURE GENETICS, 43 , pp. 333-U153.

Mather AN; Fairbairn TA; Ball SG; Greenwood JP; Plein S (2011) Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. HEART, 97 , pp. 453-459.

Cleland JGF; Calvert M; Freemantle N; Arrow Y; Ball SG; Bonser RS; Chattopadhyay S; Norell MS; Pennell DJ; Senior R (2011) The Heart Failure Revascularisation Trial (HEART). EUROPEAN JOURNAL OF HEART FAILURE, 13 , pp. 227-233.

Maqbool A; Keswani A; Galloway S; O'Regan DJ; Ball SG; Turner NA; Porter KE (2011) MMP-3 (5A/6A) Polymorphism Does Not Influence Human Smooth Muscle Cell Invasion. Journal of Surgical Research, .

Radjenovic A; Bigands JD; Larghat A; Ridgway JP; Ball SG; Greenwood JP; Jerosch-Herold M; Plein S (2010) Estimates of Systolic and Diastolic Myocardial Blood Flow by Dynamic Contrast-Enhanced MRI. MAGNETIC RESONANCE IN MEDICINE, 64 , pp. 1696-1703.

Assimes TL; Holm H; Kathiresan S; Reilly MP; Thorleifsson G; Voight BF; Erdmann J; Willenborg C; Vaidya D; Xie C; Patterson CC; Morgan TM; Burnett MS; Li M; Hlatky MA; Knowles JW; Thompson JR; Absher D; Iribarren C; Go A; Fortmann SP; Sidney S; Risch N; Tang H; Myers RM; Berger K; Stoll M; Shah SH; Thorgeirsson G; Andersen K; Havulinna AS; Herrera JE; Faraday N; Kim Y; Kral BG; Mathias RA; Ruczinski I; Suktitipat B; Wilson AF; Yanek LR; Becker LC; Linsel-Nitschke P; Lieb W; Koenig IR; Hengstenberg C; Fischer M; Stark K; Reinhard W; Winogradow J; Grassl M; Grosshennig A; Preuss M; Schreiber S; Wichmann H; Meisinger C; Yee J; Friedlander Y; Do R; Meigs JB; Williams G; Nathan DM; MacRae CA; Qu L; Wilensky RL; Jr MWH; Qasim AN; Hakonarson H; Pichard AD; Kent KM; Satler L; Lindsay JM; Waksman R; Knouff CW; Waterworth DM; Walker MC; Mooser VE; Marrugat J; Lucas G; Subirana I; Sala J; Ramos R; Martinelli N; Olivieri O; Trabetti E; Malerba G; Pignatti PF; Guiducci C; Mirel D; Parkin M; Hirschhorn JN; Asselta R; Duga S; Musunuru K; Daly MJ; Purcell S; Eifert S; Braund PS; Wright BJ; Balmforth AJ; Ball SG; Ouwehand WH; Deloukas P; Scholz M; Cambien F; Huge A; Scheffold T; Salomaa V; Girelli D; Granger CB; Peltonen L; McKeown PP; Altshuler D; Melander O; Devaney JM; Epstein SE; Rader DJ; Elosua R; Engert JC; Anand SS; Hall AS; Ziegler A; O'Donnell CJ; Spertus JA; Siscovick D; Schwartz SM; Becker D; Thorsteinsdottir U; Stefansson K; Schunkert H; Samani NJ; Quertermous T; Genet MI; Control WTC; Cardiogenics (2010) Lack of Association Between the Trp719Arg Polymorphism in Kinesin-Like Protein-6 and Coronary Artery Disease in 19 Case-Control Studies. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56 , pp. 1552-1563.

Mather AN; Crean A; Abidin N; Worthy G; Ball SG; Plein S; Greenwood JP (2010) Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 12 .

Maqbool A; West RM; Galloway SL; Drinkhill MJ; Mary DASG; Greenwood JP; Ball SG (2010) Resting sympathetic nerve activity is related to age, sex and arterial pressure but not to alpha(2)-adrenergic receptor subtype. JOURNAL OF HYPERTENSION, 28 , pp. 2084-2093.

Turner NA; Warburton P; O'Regan DJ; Ball SG; Porter KE (2010) Modulatory effect of interleukin-1 alpha on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: Role of p38 MAP kinase. MATRIX BIOLOGY, 29 , pp. 613-620.

Mughal RS; Scragg JL; Lister P; Warburton P; Riches K; O'Regan DJ; Ball SG; Turner NA; Porter KE (2010) Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein. DIABETOLOGIA, 53 , pp. 1761-1771.

Craddock N; Hurles ME; Cardin N; Pearson RD; Plagnol V; Robson S; Vukcevic D; Barnes C; Conrad DF; Giannoulatou E; Holmes C; Marchini JL; Stirrups K; Tobin MD; Wain LV; Yau C; Aerts J; Ahmad T; Andrews TD; Arbury H; Attwood A; Auton A; Ball SG; Balmforth AJ; Barrett JC; Barroso I; Barton A; Bennett AJ; Bhaskar S; Blaszczyk K; Bowes J; Brand OJ; Braund PS; Bredin F; Breen G; Brown MJ; Bruce IN; Bull J; Burren OS; Burton J; Byrnes J; Caesar S; Clee CM; Coffey AJ; Connell JMC; Cooper JD; Dominiczak AF; Downes K; Drummond HE; Dudakia D; Dunham A; Ebbs B; Eccles D; Edkins S; Edwards C; Elliot A; Emery P; Evans DM; Evans G; Eyre S; Farmer A; Ferrier IN; Feuk L; Fitzgerald T; Flynn E; Forbes A; Forty L; Franklyn JA; Freathy RM; Gibbs P; Gilbert P; Gokumen O; Gordon-Smith K; Gray E; Green E; Groves CJ; Grozeva D; Gwilliam R; Hall A; Hammond N; Hardy M; Harrison P; Hassanali N; Hebaishi H; Hines S; Hinks A; Hitman GA; Hocking L; Howard E; Howard P; Howson JMM; Hughes D; Hunt S; Isaacs JD; Jain M; Jewell DP; Johnson T; Jolley JD; Jones IR; Jones LA; Kirov G; Langford CF; Lango-Allen H; Lathrop GM; Lee J; Lee KL; Lees C; Lewis K; Lindgren CM; Maisuria-Armer M; Maller J; Mansfield J; Martin P; Massey DCO; McArdle WL; McGuffin P; McLay KE; Mentzer A; Mimmack ML; Morgan AE; Morris AP; Mowat C; Myers S; Newman W; Nimmo ER; O'Donovan MC; Onipinla A; Onyiah I; Ovington NR; Owen MJ; Palin K; Parnell K; Pernet D; Perry JRB; Phillips A; Pinto D; Prescott NJ; Prokopenko I; Quail MA; Rafelt S; Rayner NW; Redon R; Reid DM; Renwick A; Ring SM; Robertson N; Russell E; St Clair D; Sambrook JG; Sanderson JD; Schuilenburg H; Scott CE; Scott R; Seal S; Shaw-Hawkins S; Shields BM; Simmonds MJ; Smyth DJ; Somaskantharajah E; Spanova K; Steer S; Stephens J; Stevens HE; Stone MA; Su Z; Symmons DPM; Thompson JR; Thomson W; Travers ME; Turnbull C; Valsesia A; Walker M; Walker NM; Wallace C; Warren-Perry M; Watkins NA; Webster J; Weedon MN; Wilson AG; Woodburn M; Wordsworth BP; Young AH; Zeggini E; Carter NP; Frayling TM; Lee C; McVean G; Munroe PB; Palotie A; Sawcer SJ; Scherer SW; Strachan DP; Tyler-Smith C; Brown MA; Burton PR; Caulfield MJ; Compston A; Farrall M; Gough SCL; Hall AS; Hattersley AT; Hill AVS; Mathew CG; Pembrey M; Satsangi J; Stratton MR; Worthington J; Deloukas P; Duncanson A; Kwiatkowski DP; McCarthy MI; Ouwehand WH; Parkes M; Rahman N; Todd JA; Samani NJ; Donnelly P; Control WTC (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. NATURE, 464 , pp. 713-U86.

Brown BD; Nsengimana J; Barrett JH; Lawrence RA; Steiner L; Cheng S; Bishop DT; Samani NJ; Ball SG; Balmforth AJ; Hall AS (2010) An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study. BMC MEDICINE, 8 .

Riches K; Morley ME; Turner NA; O'Regan DJ; Ball SG; Peers C; Porter KE (2009) Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 47 , pp. 391-399.

Turner NA; Das A; Warburton P; O'Regan DJ; Ball SG; Porter KE (2009) Interleukin-1 alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 297 , pp. H1117-H1127.

Younger JF; Plein S; Crean A; Ball SG; Greenwood JP (2009) Visualization of coronary venous anatomy by cardiovascular magnetic resonance. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 11 .

Greenwood JP; Maredia N; Radjenovic A; Brown JM; Nixon J; Farrin AJ; Dickinson C; Younger JF; Ridgway JP; Sculpher M; Ball SG; Plein S (2009) Clinical evaluation of magnetic resonance imaging in coronary heart disease: The CE-MARC study. TRIALS, 10 .

Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ; Grp MS (2009) Polymorphisms of Adrenoceptors are Not Associated With an Increased Risk of Adverse Event in Heart Failure: A MERIT-HF Substudy. JOURNAL OF CARDIAC FAILURE, 15 , pp. 435-441.

Tregouet D; Koenig IR; Erdmann J; Munteanu A; Braund PS; Hall AS; Grosshennig A; Linsel-Nitschke P; Perret C; DeSuremain M; Meitinger T; Wright BJ; Preuss M; Balmforth AJ; Ball SG; Meisinger C; Germain C; Evans A; Arveiler D; Luc G; Ruidavets J; Morrison C; van der Harst P; Schreiber S; Neureuther K; Schaefer A; Bugert P; El Mokhtari NE; Schrezenmeir J; Stark K; Rubin D; Wichmann H; Hengstenberg C; Ouwehand W; Ziegler A; Tiret L; Thompson JR; Cambien F; Schunkert H; Samani NJ; Consor WTCC; Consortium C (2009) Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. NATURE GENETICS, 41 , pp. 283-285.

Kathiresan S; Altschuler D; Anand S; Ardissino D; Asselta R; Ball SG; Balmforth AJ; Berger K; Berglund G; Bernardi F; Bernardinelli L; Berzuini C; Braund PS; Burnett M; Burtt N; Cambien F; Casari G; Celli P; Chen Z; Corrocher R; Daly MJ; Deloukas P; Devaney J; Do R; Duga S; Elosua R; Engert JC; Epstein SE; Erdmann J; Ferrario M; Fetiveau R; Fischer M; Friedlander Y; Gabriel SB; Galli M; Gianniny L; Girelli D; Grosshennig A; Guiducci C; Hakonarson HH; Hall AS; Havulinna AS; Hengstenberg C; Hirschhorn JN; Holm H; Huge A; Kent KM; Konig IR; Korn JM; Li M; Lieb W; Lindsay JM; Linsel-Nitschke P; Lucas G; MacRae CA; Mannucci PM; Marrugat J; Martinelli N; Marziliano N; Matthai W; McCarroll SA; McKeown PP; Meigs JB; Melander O; Merlini PA; Mirel D; Morgan T; Musunuru K; Nathan DM; Nemesh J; O'Donnell CJ; Olivieri O; Ouwehand W; Parkin M; Patterson CC; Peltonen L; Peyvandi F; Piazza A; Pichard AD; Preuss M; Purcell S; Qasim A; Rader DJ; Ramos R; Reilly MP; Ribichini F; Rossi M; Sala J; Salomaa V; Samani NJ; Satler L; Scheffold T; Scholz M; Schreiber S; Schunkert H; Schwartz SM; Siscovick DS; Spertus JA; Spreafico M; Stark K; Stefansson K; Stoll M; Subirana I; Surti A; Thompson JR; Thorleifsson G; Thorsteinsdottir U; Tubaro M; Voight BF; Waksman R; Wichmann H; Wilensky R; Williams G; Wright BJ; Xie C; Yee J; Ziegler A; Zonzin P; Consortium MIG (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. NATURE GENETICS, 41 , pp. 334-341.

Erdmann J; Grosshennig A; Braund PS; Koenig IR; Hengstenberg C; Hall AS; Linsel-Nitschke P; Kathiresan S; Wright B; Tregouet D; Cambien F; Bruse P; Aherrahrou Z; Wagner AK; Stark K; Schwartz SM; Salomaa V; Elosua R; Melander O; Voight BF; O'Donnell CJ; Peltonen L; Siscovick DS; Altshuler D; Merlini PA; Peyvandi F; Bernardinelli L; Ardissino D; Schillert A; Blankenberg S; Zeller T; Wild P; Schwarz DF; Tiret L; Perret C; Schreiber S; El Mokhtari NE; Schaefer A; Maerz W; Renner W; Bugert P; Klueter H; Schrezenmeir J; Rubin D; Ball SG; Balmforth AJ; Wichmann H; Meitinger T; Fischer M; Meisinger C; Baumert J; Peters A; Ouwehand WH; Deloukas P; Thompson JR; Ziegler A; Samani NJ; Schunkert H; Thrombosis IA; Con MIG; Consor WTCC; Consortium C (2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. NATURE GENETICS, 41 , pp. 280-282.

Ainscough JFX; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG (2009) Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. CARDIOVASCULAR RESEARCH, 81 , pp. 592-600.

Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE (2009) PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma-INDEPENDENT EFFECTS OF THIAZOLIDINEDIONES ON HUMAN CARDIAC MYOFIBROBLAST FUNCTION. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 36 , pp. 478-486.

Plein S; Younger JF; Sparrow P; Ridgway JP; Ball SG; Greenwood JP (2008) Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction. JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 10 .

Younger JF; Plein S; Barth J; Ridgway JP; Ball SG; Greenwood JP (2007) Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. HEART, 93 , pp. 1547-1551.

Greenwood JP; Younger JF; Ridgway JP; Sivananthan MU; Ball SG; Plein S (2007) Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. HEART, 93 , pp. 1363-1368.

Newport M; Sirugo G; Lyons E; Vannberg F; Hill AVS; Bradbury LA; Farrar C; Pointon JJ; Wordsworth P; Brown MA; Franklyn JA; Heward JM; Simmonds MJ; Gough SCL; Seal S; Stratton MR; Rahman N; Ban M; Goris A; Sawcer SJ; Compston A; Conway D; Jallow M; Newport M; Sirugo G; Rockett KA; Kwiatkowski DP; Bumpstead SJ; Chaney A; Downes K; Ghori MJR; Gwilliam R; Hunt SE; Inouye M; Keniry A; King E; McGinnis R; Potter S; Ravindrarajah R; Whittaker P; Widden C; Withers D; Deloukas P; Leung H; Nutland S; Stevens HE; Walker NM; Todd JA; Easton D; Clayton DG; Burton PR; Tobin MD; Barrett JC; Evans DM; Morris AP; Cardon LR; Cardin NJ; Davison D; Ferreira T; Pereira-Gale J; Hallgrimsdottir IB; Howie BN; Marchini JL; Spencer CCA; Su Z; Teo YY; Vukcevic D; Donnelly P; Bentley D; Brown MA; Cardon LR; Caulfield M; Clayton DG; Compston A; Craddock N; Deloukas P; Donnelly P; Farrall M; Barton A; Bruce IN; Donovan H; Eyre S; Gilbert PD; Hilder SL; Hinks AM; John SL; Potter C; Silman AJ; Symmons DPM; Thomson W; Worthington J; Gough SCL; Hall AS; Hattersley AT; Hill AVS; Kwiatkowski DP; Matthew CG; McCarthy MI; Ouwehand WH; Parkes M; Pembrey M; Rahman N; Samani NJ; Stratton MR; Todd JA; Worthington J; Mitchell SL; Newby PR; Brand OJ; Carr-Smith J; Pearce SHS; Gough SCL; McGinnis R; Keniry A; Deloukas P; Reveille JD; Zhou X; Bradbury LA; Sims A; Dowling A; Taylor J; Doan T; Cardon LR; Davis JC; Pointon JJ; Savage L; Ward MM; Learch TL; Weisman MH; Wordsworth P; Brown MA (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. NATURE GENETICS, 39 , pp. 1329-1337.

Burns J; Sivananthan MU; Ball SG; Mackintosh AF; Mary DASG; Greenwood JP (2007) Relationship between central sympathetic drive and magnetic resonance Imaging-determined left ventricular mass in essential hypertension - Response. CIRCULATION, 116 , pp. E417-E417.

Burns J; Sivananthan MU; Ball SG; Mackintosh AF; Mary DASG; Greenwood JP (2007) The role of the central sympathetic drive in the growth of left ventricular mass as determined by MRI in human essential hypertension. JOURNAL OF HUMAN HYPERTENSION, 21 , pp. 840-841.

Turner NA; Mughal RS; Warburton P; O'Regan DJ; Ball SG; Porter KE (2007) Mechanism of TNF alpha-induced IL-1 alpha, IL-1 beta and IL-6 expression in human cardiac fibroblasts: Effects of statins and thiazolidinediones. CARDIOVASCULAR RESEARCH, 76 , pp. 81-90.

Burns J; Sivananthan MU; Ball SG; Mackintosh AF; Mary DASG; Greenwood JP (2007) The contribution of central sympathetic drive to the reversal of left ventricular hypertrophy in human hypertension as quantified by microneurography and MRI. JOURNAL OF HUMAN HYPERTENSION, 21 , pp. 841-841.

Samani NJ; Erdmann J; Hall AS; Hengstenberg C; Mangino M; Mayer B; Dixon RJ; Meitinger T; Braund P; Wichmann H; Barrett JH; Koenig IR; Stevens SE; Szymczak S; Tregouet D; Iles MM; Pahlke F; Pollard H; Lieb W; Cambien F; Fischer M; Ouwehand W; Blankenberg S; Balmforth AJ; Baessler A; Ball SG; Strom TM; Braenne I; Gieger C; Deloukas P; Tobin MD; Ziegler A; Thompson JR; Schunkert H; WTCCC; Consortium C (2007) Genomewide association analysis of coronary artery disease. NEW ENGLAND JOURNAL OF MEDICINE, 357 , pp. 443-453.

Turner NA; Aley PK; Hall KT; Warburton P; Galloway S; Midgley L; O'Regan DJ; Wood IC; Ball SG; Porter KE (2007) Simvastatin inhibits TNF alpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 43 , pp. 168-176.

Turner NA; Hall KT; Ball SG; Porter KE (2007) Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. ATHEROSCLEROSIS, 193 , pp. 36-43.

Turner NA; Hall KT; Ball SG; Porter KE (2007) Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells.. Atherosclerosis, 193 (1), pp. 36-43.

Burton PR; Clayton DG; Cardon LR; Craddock N; Deloukas P; Duncanson A; Kwiatkowski DP; McCarthy MI; Ouwehand WH; Samani NJ; Todd JA; Donnelly P; Barrett JC; Davison D; Easton D; Evans D; Leung H; Marchini JL; Morris AP; Spencer CCA; Tobin MD; Attwood AP; Boorman JP; Cant B; Everson U; Hussey JM; Jolley JD; Knight AS; Koch K; Meech E; Nutland S; Prowse CV; Stevens HE; Taylor NC; Walters GR; Walker NM; Watkins NA; Winzer T; Jones RW; McArdle WL; Ring SM; Strachan DP; Pembrey M; Breen G; St Clair D; Caesar S; Gordon-Smith K; Jones L; Fraser C; Green EK; Grozeva D; Hamshere ML; Holmans PA; Jones IR; Kirov G; Moskvina V; Nikolov I; O'Donovan MC; Owen MJ; Collier DA; Elkin A; Farmer A; Williamson R; McGuffin P; Young AH; Ferrier IN; Ball SG; Balmforth AJ; Barrett JH; Bishop DT; Iles MM; Maqbool A; Yudasheve N; Hall AS; Braund PS; Dixon RJ; Mangino M; Stevens S; Thompson JR; Bredin F; Tremelling M; Parkes M; Drummond H; Lees CW; Nimmo ER; Satsangi J; Fisher SA; Forbes A; Lewis CM; Onnie CM; Prescott NJ; Sanderson J; Mathew CG; Barbour J; Mohiuddin MK; Todhunter CE; Mansfield JC; Ahmad T; Cummings FR; Jewell DP; Webster J; Brown MJ; Lathrop GM; Connell J; Dominiczak A; Marcano CAB; Burke B; Dobson R; Gungadoo J; Lee KL; Munroe PB; Newhouse SJ; Onipinla A; Wallace C; Xue M; Caulfield M; Farrall M; Barton A; Bruce IN; Donovan H; Eyre S; Gilbert PD; Hider SL; Hinks AM; John SL; Potter C; Silman AJ; Symmons DPM; Thomson W; Worthington J; Dunger DB; Widmer B; Frayling TM; Freathy RM; Lango H; Perry JRB; Shields BM; Weedon MN; Hattersley AT; Hitman GA; Walker M; Elliott KS; Groves CJ; Lindgren CM; Rayner NW; Timpson NJ; Zeggini E; Newport M; Sirugo G; Lynons E; Vannberg F; Brown MA; Franklyn JA; Heward JM; Simmonds MJ; Hill AVS; Bradbury LA; Farrar C; Pointon JJ; Wordsmith P; Gough SCL; Seal S; Stratton MR; Rahman N; Ban M; Goris A; Sawcer SJ; Compston A; Conway D; Jallow M; Bumpstead SJ; Chaney A; Downes K; Ghori MJR; Gwilliam R; Inouye M; Keniry A; King E; McGinnis R; Potter S; Ravindrarajah R; Whittaker P; Withers D; Easton D; Pereira-Gale J; Hallgrimsdottir IB; Howie BN; Su Z; Teo YY; Vukcevic D; Bentley D; Caulfield M; Mathew CG; Worthington J; Consortium WTCC; Syndicate BRAGGS; Collaborat BCS (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. NATURE, 447 , pp. 661-678.

Younger J; Crean A; Ball S; Plein S; Greenwood J (2007) The feasibility of whole heart magnetic resonance coronary angiography to determine the course of anomalous coronary arteries. HEART, 93 , pp. A61-A62.

Burns J; Sivananthan MU; Ball SG; Mackintosh AF; Mary DASG; Greenwood JP (2007) Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension. CIRCULATION, 115 , pp. 1999-2005.

Nsengimana J; Samani NJ; Hall AS; Balmforth AJ; Mangino M; Yuldasheva N; Maqbool A; Braund P; Burton P; Bishop DT; Ball SG; Barrett JH; Study BHFFH (2007) Enhanced linkage of a locus on chromosome 2 to premature coronary artery disease in the absence of hypercholesterolemia. EUROPEAN JOURNAL OF HUMAN GENETICS, 15 , pp. 313-319.

Ooi SY; Ball SG (2007) ACE inhibitors: their properties and role in hypertension. Prescriber, , pp. 48-56.

Alfakih K; Brown B; Lawrance RA; Warburton P; Maqbool A; Walters K; Samani NJ; Ball SG; Balmforth AJ; Hall AS (2007) Effect of a common X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) on the occurrence of premature myocardial infarction and stenotic atherosclerosis requiring revascularization. Atherosclerosis, 195 (1), pp. e32-e38.

Savva J; Maqbool A; Turner NA; Warburton P; Ball SG; Balmforth AJ (2006) Identification of haplotypes of the human A(2c)-adrenergic receptor and their associated function. HEART, 92 .

Burns J; Mary DASG; Mackintosh AF; Ball SG; Greenwood JP (2006) Bendroflumethiazide therapy increases sympathetic nerve activity in essential hypertension. JOURNAL OF HYPERTENSION, 24 , pp. S385-S386.

Ball SG (2006) beta blockers for the treatment of primary hypertension. LANCET, 367 , pp. 209-210.

Smith WHT; Nair RU; Adamson D; Kearney MT; Ball SG; Balmforth AJ (2005) Somatostatin receptor subtype expression in the human heart: differential expression by myocytes and fibroblasts. JOURNAL OF ENDOCRINOLOGY, 187 , pp. 379-386.

Samani NJ; Burton P; Mangino M; Ball SG; Balmforth AJ; Barrett J; Bishop T; Hall A; Samani NJ; Stribling J; de Souza P; Singh R; Ogleby J; Ridge C; Logtens E; Hopwood L; Faulkes J; Hall AS; Morrell C; Jackson BM; Barthorpe L; Burtonwood N; Dorsch M; Durham N; Forest C; Kelly N; Hall V; Lawrance R; Oldham J; Rennie E; Smith A; Thompson S; Balmforth AJ; Mangino M; Adams S; Braund P; Clemitson JR; Bodycote C; Koekemoer A; Raleigh S; Maqbool A; Yuldasheva N; Ellis S; Mason S; Midgley L; Pleasants N; Cuthbert R; Tooze PF; Braund P; Mangino M; Platts M; Fox J; Dixon R; Barrett J; Burton P; Mangino M; Sheehan N; Scurrah K; Bishop T; Pickett S; Walters K; Nsengimana J; Hall AS; Samani NJ; Balmforth AJ; Burton P; Bishop T; Ball SG; Grp BHFFHSR (2005) A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British heart foundation (BHF) family heart study. AMERICAN JOURNAL OF HUMAN GENETICS, 77 , pp. 1011-1020.

Samani NJ; Hall AS; Balmforth AJ; Mangino M; Barrett JA; Bishop T; Burton PB; Ball SG (2005) A genome-wide linkage study of 1933 families affected by premature coronary artery disease: The British Heart Foundation Family Heart Study. Circulation (Baltimore), 112 (17), pp. pp.413.

Scragg JL; Warburton P; Ball SG; Balmforth AJ (2005) Constitutive activity of human angiotensin II type-1 receptors by G(q) overexpression. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 334 , pp. 134-139.

Plein S; Greenwood JP; Ridgway JP; Cranny G; Ball SG; Sivananthan MU (2005) Cardiac magnetic resonance-directed intervention in non-ST-segment elevation acute coronary syndrome - Reply. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 46 , pp. 564-564.

Scragg JL; Ball SG; Balmforth AJ (2005) Constitutive activity of endogenous receptors by inducible G(q) overexpression. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 331 , pp. 1239-1244.

Plein S; Radjenovic A; Ridgway JP; Barmby D; Greenwood JP; Ball SG; Sivananthan MU (2005) Coronary artery disease: Myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. RADIOLOGY, 235 , pp. 423-430.

Ooi SM; McLenachan J; Thompson D; Ball SG (2005) Circulating systemic levels of interleukin and interleukin-10. Do they indicate the presence of a vulnerable plaque?. Heart, 91 , pp. pp.15.

Alfakih K; Lawrance RA; Maqbool A; Walters K; Ball SG; Balmforth AJ; Hall AS (2005) The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) in a cohort of 509 families with premature coronary artery disease. EUROPEAN HEART JOURNAL, 26 , pp. 584-589.

Turner NA; O'Regan DJ; Ball SG; Porter KE (2005) Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. FASEB JOURNAL, 19 , pp. 804-+.

Turner NA; O'Regan DJ; Ball SG; Porter KE (2005) Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. The FASEB Journal, 19 (7), pp. 1-21.

Sedo AJ; Drinkhill MJ; Ball SG; Balmforth AJ; Ainscough JFX (2005) Conditional expression of human Angiotensin II type I receptors in adult mouse cardiac myocytes. Transgenic Research, 14 (4), pp. pp.520.

Plein S; Greenwood JP; Ridgway JP; Cranny G; Ball SG; Sivananthan MU (2004) Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 44 , pp. 2173-2181.

Porter KE; Turner NA; O'Regan DJ; Ball SG (2004) Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. CARDIOVASCULAR RESEARCH, 64 , pp. 507-515.

Ooi SY; Ball SG (2004) Statins and rheumatoid arthritis. LANCET, 364 , pp. 1853-1854.

Turner NA; O'Regan DJ; Ball SG; Porter KE (2004) Endothelin-1 is an essential co-factor for beta(2)-adrenergic receptor-induced proliferation of human cardiac fibroblasts. FEBS LETTERS, 576 , pp. 156-160.

Burns J; Mary DASG; Mackintosh AF; Ball SG; Greenwood JP (2004) Arterial pressure lowering effect of chronic atenolol therapy in hypertension and vasoconstrictor sympathetic drive. HYPERTENSION, 44 , pp. 454-458.

Scragg JL; Fearon IM; Boyle JP; Ball SG; Varadi G; Peers C (2004) Alzheimer's amyloid peptides mediate hypoxic up-regulation of L-type Ca2+ channels. FASEB JOURNAL, 18 , pp. 150-+.

Dorsch MF; Lawrance RA; Sapsford RJ; Durham N; Das R; Jackson BM; Morrell C; Ball SG; Robinson MB; Hall AS; Grp EMMACES (2004) An evaluation of the relationship between specialist training in cardiology and implementation of evidence-based care of patients following acute myocardial infarction. INTERNATIONAL JOURNAL OF CARDIOLOGY, 96 , pp. 335-340.

Burns J; Mary DASG; Mackintosh AF; Ball SG; Greenwood JP (2004) The effect of atenolol on central sympathetic drive and its peripheral vasomotor effect in hypertension. JOURNAL OF HYPERTENSION, 22 , pp. S68-S68.

Smith PA; Meaney JFM; Graham LN; Stoker JB; Mackintosh AF; Mary DASG; Ball SG (2004) Relationship of neurovascular compression to central sympathetic discharge and essential hypertension. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 43 , pp. 1453-1458.

Porter KE; Turner NA; O'Regan DJ; Balmforth AJ; Ball SG (2004) Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. CARDIOVASCULAR RESEARCH, 61 , pp. 745-755.

Ooi SY; Ball SG (2004) ACE inhibitors: their properties and current place in therapy.. Prescriber, 15 (9), pp. 33-44.

Burns J; Sivananthan UM; Mary D; Mackintosh AF; Ball SG; Greenwood JP (2004) Sympathetic nerve activity and the magnitude of left ventricular mass (LVM) assessed by cardiac MRI. . Heart, 90 (2), pp. pp.199.

Burns J; Sivananthan UM; Mary D; Mackintosh AF; Ball SG; Greenwood JP (2004) Relationship between sympathetic activation in hypertension and left ventricular hypertrophy quantified by magnetic resonance imaging. . American Journal of Hypertension, 17 (5), pp. pp.28.

Dorsch MF; Barrett JA; Lawrance RA; Maqbool A; Durham NP; Ellis S; Samani NJ; Bishop T; Ball SG; Balmforth AJ; Hall AS (2003) Premature coronary artery disease shows no evidence of linkage to loci encoding for tissue inhibitors of matrix metalloproteinases. JOURNAL OF HUMAN GENETICS, 48 , pp. 508-513.

White HL; de Boer RA; Maqbool A; Greenwood D; van Veldhuisen DJ; Cuthbert R; Ball SG; Hall AS; Balmforth AJ; Grp MS (2003) An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study. EUROPEAN JOURNAL OF HEART FAILURE, 5 , pp. 463-468.

Ball SG (2003) Benefits of blood pressure reduction in diabetic patients. JOURNAL OF HYPERTENSION, 21 , pp. S31-S36.

Cleland JGF; Freemantle N; Ball SG; Bonser RS; Camici P; Chattopadhyay S; Dutka D; Eastaugh J; Hampton J; Large S; Norell MS; Pennell DJ; Pepper J; Sanda S; Senior R; Smith D (2003) The heart failure revascularisation trial (HEART): rationale, design and methodology. EUROPEAN JOURNAL OF HEART FAILURE, 5 , pp. 295-303.

Ball SG; White WB (2003) Debate: Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers - A gap in evidence-based medicine. AMERICAN JOURNAL OF CARDIOLOGY, 91 , pp. 15G-21G.

Turner NA; Porter KE; Smith WHT; White HL; Ball SG; Balmforth AJ (2003) Chronic beta(2)-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. CARDIOVASCULAR RESEARCH, 57 , pp. 784-792.

Goldstein S; Deedwania P; Gotleib S; Wikstrand J; Ball SG (2003) Metroprolol CR/XL on black patients with heart failure (from the Metroprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure) . American Journal of Cardiology, 92 , pp. 478-480.

Greenwood JP; Plein S; Barmby D; Ridgway JP; Ball SG; Sivananthan UM (2003) 2D and 3D Delayed Enhancement MRI following Acute Myocardial Infarction: Variability of infarct quantification . Journal of Cardiovascular Magnetic Resonance, 5 (1), pp. pp.100.

Berkin KE; Ball SG (2003) Heart Failure management. . Prescriber, 14 (22), pp. 49-50.

Ball SG (2003) Benefits of blood pressure reduction in diabetic patients. Journal of Hypertension, Supplement, 21 (6), pp. S31-S36.

Plein S; Greenwood JP; Ridgway JP; Ball SG; Sivananthan UM (2003) Cardiac MRI in non-ST elevation Acute Coronary Syndromes. Circulation, 108 (17), pp. pp.378.

Fox KM; Bertrand M; Ferrari R; Ball SG; Hall AS (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) . The Lancet, 362 (9386), pp. 782-788.

Janosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson H; Ball SG (2003) Metroprolol CR/XL in postmyocardial infarction patients with chronic heart failure: Experiences from MERIT-HF . American Heart Journal, 146 , pp. 721-728.

Agis-Torres A; Ball SG; Vaughan PFT (2002) Chronic treatment with nicotine or potassium attenuates depolarisation-evoked noradrenaline release from the human neuroblastoma SH-SY5Y. NEUROSCIENCE LETTERS, 331 , pp. 167-170.

Dickstein K; Kjekhus J; Ball SG (2002) Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. The Lancet, 360 (9335), pp. 752-760.

White HL; Maqbool A; McMahon AD; Yates L; Ball SG; Hall AS; Balmforth AJ (2002) An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events - A WOSCOPS substudy. EUROPEAN HEART JOURNAL, 23 , pp. 1087-1092.

Ball SG (2002) Thrombolysis: too old and too young. HEART, 87 , pp. 312-313.

Wikstrand J; Hjalmarson A; Waagstein F; Fagerberg B; Goldstein S; Kjekshus J; Wedel H; Ball SG (2002) Dose of Metoprolol CR/XL and Clinical Outcomes in Heart Failure Patients. Analysis of the Experience in Merit-HF. Journal of the American College of Cardiology, 40 (3), pp. 491-498.

Torp-Pedersen C; Kober L; Ball SG; Hall AS; Brentdorp B; Ottesen MM; Berning J; Jensen G; Hampton J; Zilles P; Erbele S; Carlsen J (2002) The incomplete bucindolol evaluation in acute myocardial infarction trial (BEAT). [Clinical Trial. Evaluation Studies. Multicenter Study. Randomized Controlled Trial]. European Journal of Heart Failure, 4 (4), pp. 495-499.

Hall AS; Ball SG (2002) MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. The Lancet, 360 (23-33).

Berkin KE; Ball SG (2002) Modern approaches to heart failure treatment (Drug Review II). Prescriber, 13 (22), pp. 63-71.

Ball SG (2001) Should all patients with heart failure now receive an ACE inhibitor. EUROPEAN JOURNAL OF HEART FAILURE, 3 , pp. 635-636.

White HL; Maqbool A; McMahon A; Yates L; Ball SG; Hall AS; Balmforth AJ (2001) The Gly389 variant of the beta 1-adrenergic receptor does not confer protection against coronary events. CIRCULATION, 104 , pp. 285-285.

Berkin KE; Ball SG (2001) Essential hypertension: the heart and hypertension. HEART, 86 , pp. 467-475.

Kennedy J; Mogensen CE; Ball SG; Castaigne AD; Commerford PJ; Distiller L; Fisher BM; Gonzalez-Jaunatey J; Nosadini R; Novials A; Ostergren J; Palma-Gamiz J; Perrone-Filardi P; Schipperheijn JJ; Senges J; Trevisan R (2001) What is the relevance of the hope study in general practice?. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 55 , pp. 449-457.

Ball SG (2001) Why patients with heart failure die. EUROPEAN HEART JOURNAL, 22 , pp. 1523-1524.

Dorsch MF; Lawrance RA; Sapsford RJ; Oldham J; Greenwood DC; Jackson BM; Morrell C; Ball SG; Robinson MB; Hall AS; Grp EMMACES (2001) A simple benchmark for evaluating quality of care of patients following acute myocardial infarction. HEART, 86 , pp. 150-154.

Turner NA; Ball SG; Balmforth AJ (2001) The mechanism of angiotensin Ii-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT(1A) receptor internalisation. CELLULAR SIGNALLING, 13 , pp. 269-277.

Ball SG (2001) Why patients with heart failure die. European Heart Journal, 22 (17), pp. 1523-1524.

Berkin KE; Ball SG (2000) First dose hypotension after myocardial infarction. INTERNATIONAL JOURNAL OF CARDIOLOGY, 76 , pp. 5-6.

Fearon IM; Ball SG; Peers C (2000) Clotrimazole inhibits the recombinant human cardiac L-type Ca2+ channel alpha 1C subunit . British Journal of Pharmacology, 129 (3), pp. 547-554.

Flather MD; Yusuf S; Kober L; Pfeffer M; Hall AS; Murray GD; Torp-Pedersen C; Ball SG; Pogue J; Braunwald E; Moye L (2000) For the ACE- inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left ventricle dysfunction: a systemic overview of data from individual patients. The Lancet, 355 (9215), pp. 1575-1581.

Ball SG (2000) Discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack [letter]. The Lancet, 355 (9214), pp. 1558.

Levine SB; Fagerberg B; Waagstein F; Kjekshus J; Wikstrand J; El AD; Dietz R; Neuhaus KL; Janosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball SG; Gottlieb S; Deedwania P (2000) Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). . Journal of Neuroscience, 283 (10), pp. 1295-1302.

Fearon IM; Issacsohn I; Koch S; Varadi G; Ball SG; Peers C (2000) Splice variants reveal the region involved in oxygen sensing by recombinant human L-type Ca2+ channels. Circulation Research, 87 (7), pp. 537-539.

Spargias KS; Lindsay SJ; Kawar GI; Greenwood DC; Cowan JC; Ball SG; Hall AS (1999) QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failure. EUROPEAN HEART JOURNAL, 20 , pp. 1158-1165.

Spargias KS; Ball SG; Hall AS (1999) The prognostic significance of a history of systemic hypertension in patients randomised to either placebo or ramipril following acute myocardial infarction: evidence from the AIRE study. JOURNAL OF HUMAN HYPERTENSION, 13 , pp. 511-516.

Spargias KS; Hall AS; Ball SG (1999) Safety concerns about digoxin after acute myocardial infarction. LANCET, 354 , pp. 391-392.

Spargias KS; Lindsay SJ; Hall AS; Cowan JC; Ball SG (1999) Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure. AMERICAN JOURNAL OF CARDIOLOGY, 83 , pp. 969-+.

Maqbool A; Hall AS; Ball SG; Balmforth AJ (1999) Common polymorphisms of beta(1)-adrenoceptor: identification and rapid screening assay. LANCET, 353 , pp. 897-897.

Danks K; Wade JA; Batten TFC; Walker JH; Ball SG; Vaughan PFT (1999) Redistribution of F-actin and large dense-cored vesicles in the human neuroblastoma SH-SY5Y in response to secretagogues and protein kinase Calpha activation. Molecular Brain Research, 64 (2), pp. 236-245.

Spargias KS; Hall AS; Greenwood DC; Ball SG (1999) beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study. HEART, 81 , pp. 25-32.

Fearon IM; Palmer ACV; Balmforth AJ; Ball SG; Varadi G; Peers C (1999) Modulation of recombinant human cardiac L-type Ca2+ channel alpha1C subunits by redox agents and hypoxia. . Journal of Physiology, 514 (3), pp. 629-637.

Ball SG (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolo CR/XL randomised intervention trial in congestive heart failure (MERIT_HF). The Lancet, 353 , pp. 2001-2007.

Stephens N; Drinkhill MJ; Hall AS; Ball SG; Heagerty AM (1998) Structure and in vitro function of human subcutaneous small arteries in mild heart failure. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 274 , pp. C1298-C1305.

Ball SG (1998) Beta-blockers and antithrombotics for secondary prevention after myocardial infarction [editorial; comment]. . European Heart Journal, 19 (1), pp. 14-15.

Fearon IM; Palmer ACV; Balmforth AJ; Mikala G; Ball SG; Peers C (1998) Inhibition of recombinant human cardiac L-type Ca 2+ channel alpha 1C subunits by 3-isobtyl-1-methylxanthine. . European Journal of Pharmacology, 342 (2-3), pp. 353-358.

Ball SG; Hall AS (1998) Indications for ACE inhibitors in the early treatment of acute myocardial infarction. Systematic overview of individual data from 100,000 patients in randomised trials. Circulation (Baltimore), 97 , pp. 2202-2212.

Spargias KS; Ball SG (1998) Clinical implications for the Acute Infarction Ramipril Efficacy extension (AIREX) Study. . International Journal of Clinical Practice. Symposium Supplement, 94 , pp. 32-36.

Hall AS; Murray GD; Ball SG (1997) Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) study. LANCET, 349 , pp. 1493-1497.

Cleland JGF; Erhardt L; Murray G; Hall AS; Ball SG (1997) Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure - A report from the AIRE Study Investigators. EUROPEAN HEART JOURNAL, 18 , pp. 41-51.

Goodall AR; Turner NA; Walker JH; Ball SG; Vaughan PFT (1997) Activation of protein kinase C-alpha and translocation of the myristoylated alanine-rich C-kinase substrate correlate with phorbol ester-enhanced noradrenaline release from SH-SY5Y human neuroblastoma cells. . Journal of Neurochemistry, 68 (1), pp. 392-401.

Megamy SG; Hall AS; Ball SG (1997) ACE inhibitors after acute myocardial infarction: selection of patients and adjuvant . Journal of Cardiovascular Pharmacology, 30 (1), pp. S40-S45.

Fearon IM; Palmer ACV; Balmforth AJ; Ball SG; Mikala G; Schwartz A; Peers C (1997) Hypoxia inhibits the recombinant alpha1C subunit of the human cardiac L-type Ca2+ channel. . Journal of Physiology, 500 (3), pp. 551-556.

Ball SG; Hjalmarson A; Goldstein S; Wedel H; Elallaf D; Vitovec J; Aldershville J; Halinen M (1997) Rationale, design and organisation of the metoprolol CR/XL randomised intervention trial in heart failure (MERIT-HF). American Journal of Cardiology, 80 (9B), pp. 54J-58J.

Goodall AR; Danks K; Walker JH; Ball SG; Vaughan PFT (1997) Occurrence of two types of secretory vesicles in the human neuroblastoma SH-SY5Y. . Journal of Neurochemistry, 68 (4), pp. 1542-1552.

Balmforth AJ; Lee AJ; Warburton P; Donnelly D; Ball SG (1997) The conformational change responsible for AT1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII. . Journal of Biological Chemistry, 272 (7), pp. 4245-4251.

Balmforth AJ; Shepherd FH; Warburton P; Ball SG (1997) Evidence of an important and direct role for protein kinase C in agonist-induced phosphorylation leading to desensitization of the angiotensin AT1A receptor. . British Journal of Pharmacology, 122 (7), pp. 1469-1477.

Megarry SG; Sapsford R; Hall AS; Ball SG (1997) Do ACE inhibitors provide protection for the heart in the clinical setting of acute myocardial infarction?. DRUGS, 54 , pp. 48-58.

McDonald RL; Roberts DJ; Palmer AC; Ball SG; Vaughan PFT; Peers C (1997) Regulation of [Ca++]i in human neuroblastoma (SH-SY5Y) cells expressing recombinant rat angiotensin1A receptors by angiotensin II and carbachol. . Journal of Pharmacology and Experimental Therapeutics, 281 (3), pp. 1257-1263.

Balmforth AJ; Lee AJ; Shepherd FH; Warburton P; Donnelly D; Ball SG (1997) G-protein-coupled receptors for peptide hormones: angiotensin II receptors. . Biochemical Society Transactions, 25 (3), pp. 1041-1046.

Balmforth AJ; Lee AJ; Warburton P; Donnelly D; Ball SG (1997) The specificity of Peptide-Binding of the Angiotensin AT1 receptor is Dependent on an Interaction Between Transmembrane Helices III and VII. Journal of Biological Chemistry, 272 , pp. 4245-4251.

Hall AS; Sapsford R; Megarry SG; Ball SG (1996) Inhibition of the renin-angiotensin system after acute myocardial infarction - Treat first, select later?. HEART, 76 , pp. 73-78.

Narang R; Cleland JGF; Erhardt L; Ball SG; Coats AJS; Cowley AJ; Dargie HJ; Hall AS; Hampton JR; PooleWilson PA (1996) Mode of death in chronic heart failure - A request and proposition for more accurate classification. EUROPEAN HEART JOURNAL, 17 , pp. 1390-1403.

Ball SG; Hall AS (1996) Who should be treated with angiotensin-converting enzyme inhibitors after myocardial infarction?. AMERICAN HEART JOURNAL, 132 , pp. 244-250.

Ball SG; Hall AS (1996) How ACE inhibitors reduce death from myocardial infarction: hypotheses from the AIRE study. Acute Infarction Ramipril Efficacy study.. Br J Clin Pract Suppl, 84 , pp. 31-35.

Reynolds G; Hall AS; Ball SG (1996) What have the ACE inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 49 , pp. S35-S39.

Grosman H; Ball SG (1996) Bilateral spontaneous dissecting aneurysm of the internal carotid arteries: report of two cases. . Canadian Association of Radiologists Journal, 47 (5), pp. 365-369.

Lindsay HSJ; Ball SG (1996) ACE inhibitors in the Treatment of Myocardial Infarction. . Reviews in Contemporary Pharmacotherapy, 7 (1), pp. 39-53.

Turner NA; Walker JH; Ball SG; Vaughan PFT (1996) Down-regulation or long-term inhibition of protein kinase C (PKC) reduces noradrenaline release evoked via either PKC-dependent or PKC-independent pathways in human SH-SY5Y neuroblastoma cells. . Neuroscience Letters, 220 , pp. 37-40.

Ball SG; Moss AJ (1996) Management of heart failure: current status and future aspects. . European Journal of Clinical Pharmacology, 49 ((supplement 1)), pp. pp.S1.

Turner NA; Walker JH; Ball SG; Vaughan PFT (1996) Phorbol ester-enhanced noradrenaline secretion correlates with the presence and activity of protein kinase C-alpha in human SH-SY5Y neuroblastoma cells. . Journal of Neurochemistry, 66 (6), pp. 2381-2389.

Martinez C; Ball SG (1995) Cost-effectiveness of ramipril therapy for patients with clinical evidence of heart failure after acute myocardial infarction. . British Journal of Clinical Practice, 49 (78), pp. 875-880.

McDonald RL; Balmforth AJ; Palmer ACV; Ball SG; Peers C; Vaughan PFT (1995) The effect of the angiotensin ll (AT 1A) receptor stably transfected into human neuroblastoma SH-SY5Y cells on oradrenaline release and changes in intracellular calcium. . Neuroscience Letters, 199 , pp. 115-118.

Vaughan PFT; Kaye DF; Ball SG; Reeve HL; Peers C (1995) The effect of barium on [3H] noradrenaline release from the human neuroblastoma SH-SY5Y. . European Journal of Neuroscience, 7 (5), pp. 875-880.

Hall AS; Ball SG (1995) Clinical Background to the use of ACE iinhibitor therapy after myocardial infarction. . Journal of Cardiovascular Risk, 2 (5), pp. 396-405.

Latini R; Maggioni AP; Flather MD; Sleight P; Tognoni G; Ball SG (1995) ACE-Inhibitor Use in Patients with Myocardial Infarction. Summary of Evidence from Clinical Trials. . Circulation, 92 , pp. 3132-3137.

Hall AS; Ball SG (1995) ACE-inhibition after myocardial infarction. Practical aspects based on the AIRE study. . Thoraxcentre Journal, 7 (2), pp. 4-8.

Ball SG; Wintersgill HP; Warburton P; Bryson S; Balmforth AJ (1995) Glucocorticoids regulate the expression of angiotensin AT1 receptors, in the human hepatoma cell line, PLC-PRF-5.. European Journal of Pharmacology, 288 , pp. 365-371.

Hall AS; Ball SG (1995) Update on the use of ACE-inhibition therapy after acute myocardial infarction. . Expert Opinion on Investigational Drugs, 4 (2), pp. 143-146.

Balmforth AJ; Lee AJ; Bajaj P; Dickinson CJ; Warburton P; Ball SG (1995) Functional domains of the c-terminus of the rat angiotensin AT1a receptor.. European Journal of Pharmacology, 291 , pp. 135-141.

Ball SG; Hall AS; Murray GD (1995) Angiotensin -- Converting Enzyme Inhibitors after Myocardial Infarction: Indications and Timing.. Journal of the American College of Cardiology, 25 (7), pp. 42S-46S.

BALL S; HALL A; TAN L (1994) INHIBITION OF ACE/KININASE-II AFTER MYOCARDIAL-INFARCTION - ADDENDUM. CARDIOVASCULAR RESEARCH, 28 , pp. 199-200.

Balmforth AJ; Bryson S; Aylett AJ; Warburton P; Ball SG; Pun KT; Middlemiss D; Drew GM (1994) Comparative pharmacology of recominant rat AT 1A AT 1B and human AT1 receptors expressed by transfected COS-M6 cells. British Journal of Pharmacology, 112 , pp. 277-281.

Hall AS; Ball SG (1994) Inhibition of ACE/kininase-ll, acute myocardial and survial (Review). Cardiovascular Research, 28 , pp. 190-198.

Balmforth AJ; Bryson S; Aylett AJ; Warburton P; Ball SG; Pun KT; Middlemiss D; Drew GM (1994) Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells.. British Journal of Pharmacology, (112), pp. 277-281.

Turner NA; Ball SG; McMorris FA; Rumsby MG; Vaughan PFT; Walker JH (1994) A Role for protein kinase C subtypes alpha and epsilon in phorbol-ester-enhanced K+ - and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y. . Biochemical Journal, 297 , pp. 407-413.

Ball SG (1994) ACE inhibitors: a patient lifeline?. The Practitioner, 238 , pp. 848-852.

Hall AS; Ball SG (1994) ACE- inhibitor therapy after myocardial infarction. A new treatment strategy. . None, , pp. 57-62.

Ball SG (1994) ACE-inhibitors post Ml: Where are we now?. Prescriber, (supplement), pp. 3-8.

Ball SG; Hall AS; Murray GD (1994) ACE-inhibition, atherosclerosis and myocardial infarction - The AIRE study in practice. . European Heart Journal, 15 , pp. 20-25.

Ball SG; Hall AS (1994) What to expect from ACE-inhibitors after myocardial infarction. . British Heart Journal, 72 , pp. S70-S74.

Ball SG; Hall AS (1994) ACE-inhibition after myocardial infarction. Practical aspects based on the AIRE study.. None, , pp. 7-10.

Vaughan PFT; Kaye DF; Reeve HL; Ball SG; Peers C (1993) Nicotinic receptor-mediated release of noradrenalinein the human neuroplastoma SH-SY5Y.. Journal of Neurochemistry, 60 , pp. 2159-2166.

Hall AS; Bryson S; Vaughan PFT; Ball SG; Balmforth AJ (1993) Pharmacological characterization of the dopamine receptor coupled to cyclic AMP formation expressed by rat mesenteric artery vascular smooth muscle cells in culture.. British Journal of Pharmacology, 110 , pp. 681-686.

Ball SG (1993) The effect of inhibitors of eicosanoid metabolism on release of [3H] noradrenaline from the human neuroblastoma, SH-SY5Y.. Journal of Neurochemistry, 60 , pp. 1365-1371.

Hall AS; Bryson S; Ball SG; Balmforth AJ (1993) Phenoxybenzamine mediated inhibition of the vascular dopamine D1 receptor.. European Journal of Pharmacology, 247 , pp. 249-255.

Ball SG; Hall AS; Mackintosh AF; Winter C; Tan LB; Cowan JC; Reynolds GW; Akbary MA; Bender N; Rangoonwala B; Stonier P (1993) Effect of ramipril and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet, 342 (8875), pp. 821-828.

Hall AS; Ball SG (1993) Phaeochromocytoma . None, 43 , pp. S29-S38.

Otterstad JE; Davies M; Ball SG; Erikseen J; Birkin E; Virk S; Rynning SE; Rodevand O; Hansson L; Khokar AA; Areskog NH; Nylander E; Smith S; Marlow HF; Bergbrandt A; Birkin E; Erikseen J (1993) Left Ventricular hypertrophy and myocardial ischaemia in hypertension. . European Heart Journal, 14 , pp. 1622-1628.

Ball SG (1993) Early or Late ACE Inhibition After Myocardial Infarction. . Journal of Cardiovascular Pharmacology, 22 , pp. S18-S21.

Wintersgill HP; Warburton P; Bryson S; Ball SG; Balmforth AJ (1992) Characterisation of the angiotensin II receptor expressed by the human hepatoma cell line,PLC-PRF-5.. European Journal of Pharmacology, 227 , pp. 283-291.

Bryson S; Drew GM; Hall AS; Ball SG; Balmforth AJ (1992) Pharmacological characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture. . European Journal of Pharmacology, 225 , pp. 1-7.

Bryson S; Warburton P; Wintersgill HP; Drew GM; Michel AD; Ball SG; Balmforth AJ (1992) Induction of the angiotensin AT2 receptor subtype expression by differentiation of the neuroblastoma x glioma hybrid, NG-108-15.. European Journal of Pharmacology, 225 , pp. 119-127.

Hall AS; Bryson S; Ball SG; Balmforth AJ (1991) Pharmacological characterization of the B-adrenoceptor coupled to cyclic AMP formation expressed by rat mesentric artery vascular smooth muscle cells in culture. . Journal of Hypertension. Supplement, 9 (supplement 6), pp. S96-S97.

Balmforth AJ; Warburton P; Ball SG (1990) Homologous Desensitization of the D1-dopamine receptor.. Journal of Neurochemistry, 55 , pp. 2111-2116.

Balmforth AJ; Yasunari K; Vaughan PFT; Ball SG (1989) Glucocorticoids vascular smooth muscle cells express dopamine and prostaglandin E1-mediated cyclic AMP formation by the cultured human astrocytoma clone D384. . Journal of Neurochemistry, 52 , pp. 1613-1618.

Balmforth AJ; Yasunari K; Vaughan PFT; Ball SG (1988) Characterization of dopamine and B-Adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma. . Journal of Neurochemistry, 51 , pp. 1510-1515.